Metabolic health, cardiovascular resilience, cognitive function, and long-term protection against neurodegeneration are all plausibly within reach of a therapeutic strategy that addresses both the hormonal and metabolic dimensions of the menopausal transition simultaneously
Current UK practice, as outlined in the Centre for Perioperative Care (CPOC) guidance and UK Clinical Pharmacy Association (UKCPA) Handbook of Perioperative Medicines, generally advises that weekly GLP-1 receptor agonists can be continued before elective surgery with standard fasting, but individualised assessment is recommended for patients with significant gastrointestinal symptoms or high aspiration risk
Should I stop tirzepatide if my period changes
Avoid common nausea triggers during peak-effect days: fried foods, high-fat meals, strong smells, and rapid position changes
Results showed those receiving GLP-1 receptor agonists reported fewer skin-related adverse events compared with those receiving DPP-IVs (PRR = 0.27